Localized delivery of anti-PD-L1 to tumor-draining LNs is sufficient to block these interactions and mobilize stem-like CD8+ Tex from the lymphatics for proliferation, migration to the TME, and preservation of stemness, leading to an increase in host survival comparable to systemic delivery (89). Here, CD8A is linked to neoplasm.